Neutralization of Enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products

Journal of Clinical Virology

Volumn 69, Issue , 2015, Pages 172-175

  Zhang, Yiting ^a   Moore, Deborah D ^a   Nix, W Allan ^a   Oberste, M Steven ^a   Weldon, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antibody titers; Enterovirus D68; Intravenous immunoglobulin

Indexed keywords

IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; IMMUNOLOGIC FACTOR;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENTEROVIRUS D; ENTEROVIRUS D68; ENTEROVIRUS INFECTION; EPIDEMIC; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SEROPREVALENCE; UNITED STATES; VIRUS CAPSID; VIRUS NEUTRALIZATION; ENTEROVIRUS INFECTIONS; EPIDEMIOLOGY; HUMAN; IMMUNOLOGY;

ANTIBODIES, NEUTRALIZING; CAPSID; DISEASE OUTBREAKS; ENTEROVIRUS D, HUMAN; ENTEROVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; UNITED STATES;

EID: 84937886006     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.06.086     Document Type: Article

References (19)

1. Oberste M.S., Maher K., Schnurr D., Flemister M.R., Lovchik J.C., Peters H., et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 2004, 85(September (9)):2577-2584.
2. Centers for Disease C, Prevention Clusters of acute respiratory illness associated with human Enterovirus 68 - Asia, Europe, and US, 2008-2010. MMWR Morb. Mortal. Wkly. Rep. 2011, 60(September (38)):1301-1304.
3. Centers for Disease C, Prevention. (2014) (03.09.15). http://www.cdc.gov/non-polio-enterovirus/outbreaks/EV-D68-outbreaks.html.
4. Arora R., Kaplan M., Nelson M. Enterovirus-specific IgG in intravenous immunoglobulin preparations. Ann. Allergy Asthma Immunol.: Off. Pub. Am. Coll. Allergy Asthma Immunol. 2011, 106(June (6)):544-545.
5. Abzug M.J., Keyserling H.L., Lee M.L., Levin M.J., Rotbart H.A. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin. Infect. Dis.: Off. Pub. Infect. Dis. Soc. Am. 1995, 20(May (5)):1201-1206.
6. Pasic S., Jankovic B., Abinun M., Kanjuh B. Intravenous immunoglobulin prophylaxis in an echovirus 6 and echovirus 4 nursery outbreak. Pediatr. Infect. Dis. J. 1997, 16(July (7)):718-720.
7. Kärber G. Beitrag zur kollektiven behandlung pharmakologischer reihenversuche. Arch. Exp. Pathol. Pharm. 1931, 162:480-483.
8. Liu Y., Sheng J., Fokine A., Meng G., Shin W.H., Long F., et al. Virus structure. Structure and inhibition of EV-D68, a virus that causes respiratory illness in children. Science 2015, 347(January (6217)):71-74.
9. Jegaskanda S., Vandenberg K., Laurie K.L., Loh L., Kramski M., Winnall W.R., et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses. J. Infect. Dis. 2014, 210(December (11)):1811-1822.
10. Hung I.F., To K.K., Lee C.K., Lee K.L., Yan W.W., Chan K., et al. Hyperimmune IV. Immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. Chest 2013, 144(August (2)):464-473.
11. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group, Pediatrics 99(1) (1997) 93-99.
12. Planitzer C.B., Farcet M.R., Schiff R.I., Ochs H.D., Kreil T.R. Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin. J. Med. Virol. 2011, 83(February (2)):305-310.
13. Wu C.Y., Wang H.C., Wang K.T., Weng S.C., Chang W.H., Shih D.Y., et al. Neutralization of five subgenotypes of Enterovirus by Taiwanese human plasma and Taiwanese plasma derived intravenous immunoglobulin. Biol.: J. Int. Assoc. Biol. Standardization 2013, 41(May (3)):154-157.
14. Sherry B., Mosser A.G., Colonno R.J., Rueckert R.R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 1986, 57(January (1)):246-257.
15. Smura T., Ylipaasto P., Klemola P., Kaijalainen S., Kyllonen L., Sordi V., et al. Cellular tropism of human Enterovirus D species serotypes EV-, EV-70, and EV-68 in vitro: implications for pathogenesis. J. Med. Virol. 2010, 82(November (11)):1940-1949.
16. Simon H.U., Spath P.J. IVIG - mechanisms of action. Allergy 2003, 58(July (7)):543-552.
17. Norrby-Teglund A., Basma H., Andersson J., McGeer A., Low D.E., Kotb M. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin. Infect. Dis.: Off. Pub. Infect. Dis. Soc. Am. 1998, 26(March (3)):631-638.
18. Lamari F., Anastassiou E.D., Tsegenidis T., Dimitracopoulos G., Karamanos N.K. An enzyme immunoassay to determine the levels of specific antibodies toward bacterial surface antigens in human immunoglobulin preparations and blood serum. J. Pharm. Biomed. anal. 1999, 20(September (6)):913-920.
19. Matejtschuk P., Chidwick K., Prince A., More J.E., Goldblatt D. A direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma. Vox Sang. 2002, 83(July (1)):17-22.